Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-15 Sale |
2021-03-16 7:45 pm |
LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting |
22,912 | $6.9151 | $158,440 | 122,746 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-10 Option Award |
2022-02-14 4:02 pm |
N/A 2032-02-10 |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
79,630 | $0 | 79,630 (Direct) |
View |
| 2021-04-14 Ownership |
2022-02-11 5:27 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | WADE JEFFREY L President and CFO |
4,500 | $0 | 152,520 (Direct) |
View |
| 2021-07-01 Ownership |
2022-01-10 4:17 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | SOBECKI CHRISTOPHER J Director |
5,700 | $0 | 145,697 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-04 9:34 pm |
N/A 2032-01-03 |
LEXICON PHARMACEUTICALS INC. | LXRX | McDermott Wendy VP, Human Resources |
85,185 | $0 | 85,185 (Direct) |
View |
Ownership |
2021-10-29 4:18 pm |
N/A 2025-02-05 |
LEXICON PHARMACEUTICALS INC. | LXRX | Seth Kiernan VP, Chief Commercial Officer |
0 | $0 | 241,082 (Direct) |
View |
Ownership |
2021-10-01 4:05 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA |
0 | $0 | 409,675 (Direct) |
View |
Ownership |
2021-09-27 4:06 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
0 | $0 | 58,884 (Direct) |
View |
| 2021-08-02 Option Award |
2021-08-03 4:39 pm |
N/A 2031-08-02 |
LEXICON PHARMACEUTICALS INC. | LXRX | Granowitz Craig B SVP, Chief Medical Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-03 5:07 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | SOBECKI CHRISTOPHER J Director |
10,499 | $0 | 10,499 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-03 5:06 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Swain Judith L Director |
10,499 | $0 | 10,499 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-03 5:06 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Palantoni Frank Director |
10,499 | $0 | 10,499 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-03 5:05 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | LEFKOWITZ ROBERT J MD Director |
10,499 | $0 | 10,499 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-03 5:04 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | NIES ALAN S Director |
10,499 | $0 | 10,499 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-03 5:03 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
10,499 | $0 | 10,499 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-03 5:02 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | BARKER SAM L Director |
10,499 | $0 | 10,499 (Direct) |
View |
| 2021-04-30 Option Award |
2021-05-03 5:02 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Amouyal Philippe Director |
10,499 | $0 | 10,499 (Direct) |
View |
| 2021-04-24 Exercise |
2021-04-27 4:51 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Swain Judith L Director |
10,638 | $0 | 27,006 (Direct) |
View |
| 2021-04-24 Exercise |
2021-04-27 4:50 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | SOBECKI CHRISTOPHER J Director |
10,638 | $0 | 151,397 (Direct) |
View |
| 2021-04-24 Exercise |
2021-04-27 4:49 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Palantoni Frank Director |
10,638 | $0 | 27,006 (Direct) |
View |
| 2021-04-24 Exercise |
2021-04-27 4:48 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | NIES ALAN S Director |
10,638 | $0 | 27,720 (Direct) |
View |
| 2021-04-24 Exercise |
2021-04-27 4:48 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | LEFKOWITZ ROBERT J MD Director |
10,638 | $0 | 27,006 (Direct) |
View |
| 2021-04-24 Exercise |
2021-04-27 4:47 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director |
10,638 | $0 | 4,648,735 (Direct) |
View |
| 2021-04-24 Exercise |
2021-04-27 4:46 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | BARKER SAM L Director |
10,638 | $0 | 66,291 (Direct) |
View |
| 2021-04-24 Exercise |
2021-04-27 4:45 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Amouyal Philippe Director |
10,638 | $0 | 27,006 (Direct) |
View |
| 2021-03-15 Exercise |
2021-03-16 7:45 pm |
N/A 2030-02-06 |
LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting |
12,000 | $0 | 122,746 (Direct) |
View |
| 2021-03-15 Exercise |
2021-03-16 7:45 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting |
12,000 | $3.31 | 122,746 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 5:01 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | WADE JEFFREY L EVP, Corp Adm Affairs and CFO |
68,109 | $0 | 243,243 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 5:01 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | WADE JEFFREY L EVP, Corp Adm Affairs and CFO |
26,584 | $7.19 | 243,243 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 5:00 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | TYLE PRAVEEN EVP, R&D |
68,007 | $0 | 204,771 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 5:00 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | TYLE PRAVEEN EVP, R&D |
16,560 | $7.19 | 204,771 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 5:00 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting |
28,316 | $0 | 119,508 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 5:00 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting |
10,765 | $7.19 | 119,508 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 4:59 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | MAIN ALAN J EVP, Innov & Chem Sciences |
56,468 | $0 | 209,668 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 4:59 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | MAIN ALAN J EVP, Innov & Chem Sciences |
20,413 | $7.19 | 209,668 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 4:57 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T VP, General Counsel & Secr. |
38,765 | $0 | 126,797 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 4:57 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T VP, General Counsel & Secr. |
14,860 | $7.19 | 126,797 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 4:57 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL President and CEO |
192,885 | $0 | 685,353 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 4:57 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL President and CEO |
55,038 | $7.19 | 685,353 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:43 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | WADE JEFFREY L EVP, Corp Adm Affairs and CFO |
134,130 | $0 | 134,130 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:41 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | TYLE PRAVEEN EVP, R&D |
128,410 | $0 | 128,410 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:16 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting |
40,570 | $0 | 40,570 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:14 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | MAIN ALAN J EVP, Innov & Chem Sciences |
107,710 | $0 | 107,710 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:13 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T VP, General Counsel & Secr. |
105,010 | $0 | 105,010 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:10 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL President and CEO |
400,000 | $0 | 400,000 (Direct) |
View |
Ownership |
2021-01-21 6:04 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Wittouck Amaury Director 10% Owner |
0 | $0 | 71,178,364 (Indirect) |
View |